GSK Plc (GSK)

54.58 -0.69 (-1.25%) USD  |  NYSE  |  Mar 06, 12:41
More

GSK Free Cash Flow : 5.712B for Dec. 31, 2025

Free Cash Flow Chart

View Free Cash Flow for GSK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
AstraZeneca PLC 8.977B
Mereo BioPharma Group Plc -33.02M
Novavax, Inc. -251.02M
Biodexa Pharmaceuticals Plc -14.30M
BioNTech SE -588.89M

Free Cash Flow Related Metrics

Cash from Operations (Quarterly) 2.744B
Cash from Investing (Quarterly) -3.184B
Cash from Financing (Quarterly) 1.089B
Free Cash Flow Per Share (Quarterly) 0.6832
Free Cash Flow to Equity (Quarterly) 1.457B
Free Cash Flow to Firm (Quarterly) 1.587B
Free Cash Flow Yield 5.09%